Revelation Biosciences, Inc. Warrant
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch REVBW and buy or sell other stocks, ETFs, and their options commission-free!About REVBW
Revelation Biosciences, Inc. is a clinical-stage life sciences company, which focuses on the development of immunologic-based therapies for the prevention and treatment of disease. Its product candidates include REVTx-99b, its lead therapeutic candidate being developed for allergic rhinitis and chronic nasal congestion, REVDx 501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation, and REVTx 200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity.
CEOJames M. Rolke
CEOJames M. Rolke
Employees—
Employees—
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2019
Founded2019
Employees—
Employees—
REVBW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume12.26K
Average volume12.26K
High today—
High today—
Low today—
Low today—
Open price$0.0093
Open price$0.0093
Volume0.00
Volume0.00
52 Week high$0.0231
52 Week high$0.0231
52 Week low$0.004
52 Week low$0.004
Stock Snapshot
Revelation Biosciences, Inc. Warrant(REVBW) trades at $0.01.
Revelation Biosciences, Inc. Warrant(REVBW) stock opened on 2025-12-08 at $0.01. The price climbed to — and dipped to —.
Revelation Biosciences, Inc. Warrant(REVBW) shares are trading with a volume of 0, against a daily average of 12.26K.
In the last year, Revelation Biosciences, Inc. Warrant(REVBW) shares hit a 52-week high of $0.02 and a 52-week low of $0.00.
In the last year, Revelation Biosciences, Inc. Warrant(REVBW) shares hit a 52-week high of $0.02 and a 52-week low of $0.00.